Mashup Score:3
OncLiveDr. Raghav on First-Line Treatment Options in CRC - 10 hours
Mashup Score:3
Twitter Feed: OncLive SOSS
Mashup Score:2
OncLiveDr. Patel on the Integration of CAR T-Cell Therapy in Multiple Myeloma - 11 hours
Mashup Score:2
Krina K. Patel, MD, MSc, discusses the integration of CAR T-cell therapy into the treatment paradigm of relapsed/refractory multiple...
-
Krina K. Patel, MD, MSc, of @MDAndersonNews, discusses the integration of CAR T-cell therapy into the treatment paradigm of relapsed/refractory multiple myeloma #mmsm https://t.co/zLB2OGRdC2 https://t.co/zLB2OGRdC2 - view on twitter
More coverage:
#mmsm
Mashup Score:1
OncLiveDr. Chiorean on the Role of Molecular Testing in Pancreatic Cancer - 2 days
Mashup Score:1
E. Gabriela Chiorean, MD, discusses the role of molecular testing in pancreatic...
-
E. Gabriela Chiorean, MD, of @SeattleCCA, discusses the role of molecular testing in pancreatic cancer #pancsm https://t.co/pQWuBTQOiy https://t.co/pQWuBTQOiy - view on twitter
More coverage:
#pancsm
Mashup Score:1
OncLiveDr. Dietrich on Future Research Directions in Lung Cancer - 1 day
Mashup Score:1
Martin Dietrich, MD, PhD, discusses future research directions for the treatment of patients with lung...
-
.@DoctorDietrich, of @FLCancerFound, discusses future research directions for the treatment of patients with lung cancer #lcsm https://t.co/8QeMvVFaYx https://t.co/8QeMvVFaYx - view on twitter
More coverage:
#lcsm
Peter Riedell, MD, discusses the rationale to evaluate survival outcomes after transplant in mantle cell...
-
Peter Riedell, MD, of @UChicagoMed, discusses the rationale to evaluate survival outcomes after transplant in mantle cell lymphoma #lymsm https://t.co/CA4yOLUVfc - view on twitter
More coverage:
#lymsm
Sara A. Hurvitz, MD, discusses outcomes with sacituzumab govitecan-hziy in patients with metastatic triple-negative breast...
-
Sara A. Hurvitz, MD, of @UCLAJCCC, discusses outcomes with sacituzumab govitecan-hziy in patients with metastatic triple-negative breast cancer #bcsm https://t.co/8ytIF7UDmR https://t.co/8ytIF7UDmR - view on twitter
More coverage:
#bcsm
Pradnya D. Patil, MD, FACP, discusses data from the phase 3 ADAURA trial in patients with EGFR-mutated non–small cell lung...
-
.@Pradnya_PatilMD, of @ClevelandClinic, discusses data from the phase 3 ADAURA trial in patients with EGFR-mutated non–small cell lung cancer #lcsm https://t.co/uhgtDQlilg https://t.co/uhgtDQlilg - view on twitter
More coverage:
#lcsm
Stacey A. Cohen, MD, discusses the importance of patient selection for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in colorectal...
-
Stacey A. Cohen, MD, of @SeattleCCA, discusses the importance of patient selection for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in colorectal cancer #crcsm https://t.co/Vjw5KIu3wb https://t.co/Vjw5KIu3wb - view on twitter
More coverage:
#crcsm
Neal E. Ready, MD, PhD, discusses selecting between frontline chemotherapy plus atezolizumab or durvalumab in extensive-stage small cell lung...
-
Neal E. Ready, MD, PhD, of @DukeCancer, discusses selecting between frontline chemotherapy plus atezolizumab or durvalumab in extensive-stage small cell lung cancer #lcsm https://t.co/286vZlEBjf https://t.co/286vZlEBjf - view on twitter
More coverage:
#lcsm
Harveshp D. Mogal, MD, MS, FACS, DABS, FSSO, discusses the incidence and prognosis of peritoneal carcinomatosis in colorectal...
-
.@HarveshpMogalMD, of @SeattleCCA, discusses the incidence and prognosis of peritoneal carcinomatosis in colorectal cancer #crcsm https://t.co/JrmrgsILzv https://t.co/JrmrgsILzv - view on twitter
More coverage:
#crcsm
Kanwal Raghav, MBBS, MD, discusses first-line treatment options for patients with colorectal...
Kanwal Raghav, MBBS, MD, of @MDAndersonNews, discusses first-line treatment options for patients with colorectal cancer #crcsm https://t.co/lxb5A8xR9p https://t.co/lxb5A8xR9p - view on twitter